Pan-European arthritis treatment brief heads to 90TEN Healthcare

90TEN Healthcare has won duties on the two-year rollout of a biopharmaceutical treatment for arthritis across Europe.

90TEN senior account director James Osborn: will lead the account
90TEN senior account director James Osborn: will lead the account

Inflectra is made by pharma company Hospira and is one of the first two examples of a medicine known as a monoclonal-antibody biosimilar.

A biosimilar is a close copy of a biological medicine that has already been authorised for use, in this case Remicade.

The first biosimilar was approved in Europe in 2006. According to the European Medicines Agency, Inflectra is the first time the biosimilar concept has been applied successfully to such a complex molecule as a monoclonal antibody.

Hospira, which awarded the account to 90TEN following a competitive pitch, has done limited comms work on biosimilars in Europe.

Senior account director James Osborn, who will lead the account, said: ‘A vital part of our role will be to drive engagement around how Hospira’s offering can help relieve some of the challenges faced by Europe’s healthcare systems.’

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Sky adds Fever PR to its roster after splitting with Cake

Sky adds Fever PR to its roster after splitting with Cake

Pay-TV giant Sky has added Fever PR to its agency line-up for a wide-ranging brief covering products and services.

Max Clifford trial jury to continue deliberations after Easter break

Max Clifford trial jury to continue deliberations after Easter break

The jury in the trial of celebrity publicist Max Clifford has been sent home for Easter and will reconvene on Tuesday for further deliberations about its verdicts on 11 charges of indecent assault.

Home Office brings in Munro & Forster to campaign against FGM

Home Office brings in Munro & Forster to campaign against FGM

The Home Office has tasked Munro & Forster (M&F) with supporting its campaign to eradicate female genital mutilation (FGM) as part of a wider retained brief.

Former White House press secretary Dee Dee Myers to join Warner Bros

Former White House press secretary Dee Dee Myers to join Warner Bros

Warner Bros has appointed former White House press secretary Dee Dee Myers as EVP for worldwide corporate communications and public affairs, effective September 2.